Navigation Links
BioReliance Launches Next-Generation Genotoxicity Screening Service
Date:9/12/2007

ROCKVILLE, Md., Sept. 12 /PRNewswire/ -- BioReliance Corporation, a leading contract services organization for the biopharmaceutical and pharmaceutical industries, has contracted with Gentronix to offer their GreenScreen HC in vitro assay as a major part of BioReliance's portfolio of genotoxicity screening services. GreenScreen HC, in conjunction with Ames II assays, allows pharmaceutical companies to test for genotoxic potential earlier in the preclinical development process, using only a few milligrams of test compound as opposed to the gram quantities required by current ICH regulatory tests.

John Nicholson, Chairman and CEO of Gentronix, comments, "We are delighted to complete this agreement with BioReliance, a company regarded as a global leader in genetic toxicology testing services." "This new high-throughput assay from Gentronix furthers BioReliance's ability to meet customer demand for faster and more effective genotoxic screening services," adds David Bruning, Senior Director, Toxicology Operations at BioReliance. "The GreenScreen HC and Ames II assays, when combined, offer highly predictive and sensitive detection of genotoxic compounds while minimizing false positives seen with other in vitro assays, accelerating the development process."

GreenScreen HC is a unique human cell-based genotoxicity screening assay that links the regulation of the human Growth Arrest and DNA Damage (GADD45a) gene to the production of Green Fluorescent Protein (GFP). Cells that have incurred DNA damage upon exposure to a test compound express higher levels of detectable GFP.

GreenScreen HC only requires 1 mg of starting material to demonstrate high specificity, in contrast to other in vitro genetic toxicology assays that often provide false positive results. GreenScreen HC is able to detect multiple mechanistic classes of genotoxic agents, including aneugens, and is easily adapted to automatic robotic platforms.

About Gentronix

Gentronix is
'/>"/>

SOURCE BioReliance Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Einstein Wireless launches cellular alert system
3. Logistics Health launches compliance management tool
4. UW-Madison launches new high-speed research network
5. UWM launches research foundation
6. TeraMedica launches information manager
7. GE Healthcare launches hybrid electronic record
8. Cedara launches new version of DICOM toolkit
9. Merge launches Spanish version of imaging tool
10. Doyle launches 2025 alternative energy plan
11. Jellyfish launches comparative shopping website

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...tria, November 6 EUCODIS Bioscienc...g, and marketing enzymes for the,chemical industry...ch,agreement with Bio Sidus, the leading biopharma...agreement gives EUCODIS Bioscience exclusive acces... Sidus, proprietary collection of,psychrophilic ba...
(Date:11/6/2009)... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ...ny") today announced updated results from a Phase ...th sarcomas metastatic to the lung in a poster pre...ology Society Meeting held in Miami Beach, Florida...n, entitled "A Phase II Study of Intravenous REOLY...
(Date:11/5/2009)...- Gone hybrid . . . , Fuel economy ratings for...d at the www.fueleconomy.gov web site, which Oak... for the U.S. Department of Energy and the U.S. En...vehicles on the best fuel economy list are hybrid ...8 highway). "This list proves that hybrids have go...
(Date:11/5/2009)...., Nov. 5 DSM Pharmaceutical Produ...ng alliance with Galenix, Saint Jean D,Illac, Fran...le manufacturing partner for Galenix commercial pr...ll collaborate on business development opportuniti..., based on the strength of Galenix in drug product...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
Wisconsin's unusual Internet tax stirs dissent
...nal honors on Monday as President Bush gave medals...l R. de Boor and the Wisconsin Alumni Research Fo...nology transfer, respectively. , ,The 2003 Nation... accomplishments in various fields. They included ... Ethernet, and the work that led to the first auto...
...ags "wake up" when they,re near a reader and can s..., including its history, quantity, location and co...reds of major companies are scurrying to develop s...ication (RFID) technology after fall 2003 mandates...that their suppliers be RFID-compliant, tagging ca...
Other Biology Technology:UW-Madison workgroup helps state companies tap the power of RFID 2UW-Madison workgroup helps state companies tap the power of RFID 3UW-Madison workgroup helps state companies tap the power of RFID 4
(Date:11/9/2009)...wire/ -- CBS Vision, the research division of CBS ...a Group company, today announced a new research pa...the CBS Television City research facility housed i... venture, which marries the capabilities of CBS Vi...ll be called Communications Lab@OMD . ,, CBS,s...
(Date:11/9/2009)...ytoplankton are flourishing in areas of open water...ce shelves and glaciers around the Antarctic Penin...eficial impact on climate change. As the blooms di... can store carbon for thousands or millions of yea...l Change Biology , scientists from British Antarct...
(Date:11/9/2009)...nergy (DOE) has announced plans to fund research a...hool of Engineering on technologies that would hel...ure and permanent safe storage, or sequestration, ...ration with Southern Company, the parent company o... 2009 American Recovery and Reinvestment Act, the ...
Breaking Biology News(10 mins):CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4Antarctica glacier retreat creates new carbon dioxide store 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3Mersana Reports Preliminary Phase 1 Results of XMT 1001 in Patients with Advanced Solid Tumors 12387 1Mersana Reports Preliminary Phase 1 Results of XMT 1001 in Patients with Advanced Solid Tumors 12387 2Mersana Reports Preliminary Phase 1 Results of XMT 1001 in Patients with Advanced Solid Tumors 12387 3AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 1AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 2AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 3UCB and Crohns Disease Working Group Award 24175 000 in Research Grants to Gastroenterology Fellows 12383 1UCB and Crohns Disease Working Group Award 24175 000 in Research Grants to Gastroenterology Fellows 12383 2
...ew research published online this week in the open...ic and much-studied question in the fruit fly, and...ls, male or female development depends on the pres...ales because it includes masculinizing genes. But .... James Erickson and Jerome Quintero at Texas A&M ...
...p to 20 meters long and weighing as much as 20 ton...don typus) its name. Known as the gentle giant fo...broad, flattened head and minute teeth, eats tiny ...ill-rakers. Listed as a rare species, relatively ...tropical and warm seas, including the western Atla...
... new targeted screening strategy could make the di...ble in low-resource settings, concludes a new stud...cess journal PLoS Neglected Tropical Diseases. , ...causes Chagas disease, is transmitted by triatomin... disease, which infects an estimated 11 million pe...
Other Biology News:Photo-monitoring whale sharks 2New screening strategy for detection of chagas disease in children 2
Bovine BSA, Fluorescein conjugated/tagged from Biosearch Technologies
Mouse Anti-Bovine WC1 Monoclonal Antibody, FITC Conjugated from AbD Serotec
Molecular Immunology from Promega
Peptide Antibody from Proteintech Group, Inc.
Biology Products: